Find Parking On LSU’s Campus With ParkZen App

Driving through the parking lots at LSU to search for an open parking space can be stressful for students, especially with an enrollment that has surpassed 35,000. To address this, Manos Chatzopoulos, assistant professor of Physics & Astronomy, has developed a free smartphone app to assist drivers in locating available parking on LSU's campus.

New Covid-19 Treatment Developed By Skymount Medical In Partnership With LSU Approved For Use In Patients In The United Kingdom

Skymount Medical, a drug discovery company using an artificial intelligence, or AI, platform developed by LSU researchers to repurpose and build new drugs, announced today that it has received approval from the United Kingdom’s Medicines and Healthcare products Regulatory Agency, or MHRA, to conduct a human clinical trial of its new oral therapeutic for COVID-19 patients. MHRA serves in a role similar to the U.S. Food and Drug Administration for the U.K.

LSU Hires New Louisiana Small Business Development Center State Director

LSU is now the new host organization for the statewide network that provides training and technical support to small businesses and entrepreneurs throughout Louisiana. Bryan Greenwood is the new state director of the Louisiana Small Business Development Center, or LSBDC, which is a network consisting of 10 regional offices.

Beyond Biodegradable Mardi Gras Beads

Five hundred strands of biodegradable Mardi Gras beads— formulated at LSU and made in Louisiana—will be handed out along parade routes in New Orleans this year as concern over the tens of thousands of pounds of discarded plastic beads and their impact on the environment grows. LSU Department of Biological Sciences Professor Naohiro Kato has been concerned about the problem the excess plastic from Mardi Gras poses for the environment for years; and as a biologist, he is creating solutions.

Fighting Covid-19 With LSU-Developed Artificial Intelligence

With repeat surges and the emergence of new variants, there is a rising need to continuously and effectively treat—in addition to prevent—COVID-19. While Pfizer and Merck were the first to launch antiviral treatments to ward off severe illness and death last month, another drug—discovered by LSU researchers using artificial intelligence, or AI—could soon become available.

Tenant Smalls Sliders' Future Endeavors

LSU Innovation Park tenant and LSBDC client, Smalls Sliders, discusses plans for their successful fast-food drive through.

Request for Lift2 Proposals

U.S. Clinical Trials Begin for COVID-19 Oral Therapeutics Discovered Using LSU-Developed Artificial Intelligence

First patient study in North America to investigate a new combination of two previously FDA-approved drugs identified as effective against COVID-19 by DeepDrug, an artificial intelligence platform developed by Louisiana State University (LSU) researchers.

LSU Innovation Park Tenant Tigeraire Becomes First Louisiana Startup to Raise Seed Funding from Global Top 50 Venture Capital Firm

Tigeraire, a tech startup at LSU Innovation Park, recently announced that General Catalyst, the Silicon Valley venture capital firm behind Venmo, Stripe, Airbnb, and TikTok, has signed as their lead investor. This makes Tigeraire the first company in the history of the state of Louisiana to attract seed funding from a global top 50 venture capital firm, according to Preqin and Crunchbase.

LSU Launches Office of Innovation and Ecosystem Development

LSU announced August 23, that five of LSU's entities that support innovation and business development have joined forces under the new Office of Innovation and Ecosystem Development.

Human Studies Start for Promising COVID-19 Treatment Discovered by LSU DeepDrug Team Using Artificial Intelligence

SBIR-STTR Funding Opportunities

A list of recently opened SBIR-STTR Funding Opportunities:

LSBDC at LSU Ribbon Cutting

On March 8, LSU Innovation Park hosted the Louisiana SBDC at LSU Ribbon Cutting Ceremony.

LSU DeepDrug Team Uses Artificial Intelligence to Discover New Treatments for Coronavirus

The LSU DeepDrug team, a current semifinalist for the IBM Watson AI X-PRIZE, is using artificial intelligence, or AI, to discover new drugs. Although their work so far has focused mainly on antibiotics and antimicrobials, they are now working as quickly as they can to find new antivirals effective against coronavirus. The team is in the process of retraining their AI by feeding it large datasets of information and asking it questions—some with known answers—to see how well it is learning. Within days, they hope to have their AI begin suggesting new drugs, or drug combinations, to help save lives.

Tenant Spotlight: Tigeraire

Spotlighting one of our newest tenants, Tigeraire.